Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research

耶鲁大学糖尿病研究跨学科生物工程培训补助金

基本信息

  • 批准号:
    8633896
  • 负责人:
  • 金额:
    $ 26.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-04 至 2018-09-03
  • 项目状态:
    已结题

项目摘要

ABSTRACT We propose the development of an interdisciplinary training program to prepare bioengineers for careers as independent researchers in diabetes. The long-term goal of this program is to foster the career development of biomedical engineers in interdisciplinary research related to diabetes. This program will build on Yale's considerable experience in the training of biomedical engineers, which will be coupled with world-leading programs in diabetes research. This application requests postdoctoral stipends for five postdoctoral (MD, PhD, or MD/PhD) fellows per year. This request is based on several factors: 1) The ongoing critical need for bioengineering scientists dedicated to studying diabetes. 2) The expanded opportunities afforded by our interdisciplinary training faculty. 3) The increase in the number of medical residents with engineering backgrounds. 4) The high quality of biomedical engineers applying to Yale postdoctoral programs. Our experience in interdisciplinary training indicates that three or more years of research training are needed for fellows to develop the skills needed for independent research. We believe a program specifically dedicated to introducing engineers to cutting-edge, interdisciplinary research in diabetes will lead to the development of scientists ready to build impactful research programs in diabetes. This program will have several key components: (1) Recruitment of bioengineering postdoctoral fellows with interests in diabetes. (2) Matching fellows with superb research mentors. (3) Participation of fellows in research projects with co-mentors in bioengineering and diabetes research. (4) Participation in a core didactic research curriculum. (5) Critical and rigorous scholar and program evaluation. (6) Establishment of a career guidance program. While enrolled in the program, postdoctoral fellows will have 80% of their time specifically dedicated to research, and support will be provided for 3 years. The focus of this program will be on bioengineering training, which has been identified as an area where diabetes scientists are greatly needed. To achieve these goals, we will take advantage of several established programs at Yale specifically designed for training in diabetes. Potential mentors have good NIH support and a proven record of training fellows in diabetes or biomedical engineering. Please see the required T32-related supporting tables. Table 1 lists participating departments; Table 2 lists mentors and rank; Table 3 lists mentor department training programs; Table 4 lists mentor grant support; Table 5 lists mentor trainees over the past 10 years; Table 8 lists post- doctoral applicants for fellowships over the past 5 years. It is anticipated that this program will lead to the training of exceptional bioengineers, who will embark on promising careers focusing on interdisciplinary diabetes research.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

W. Mark Saltzman其他文献

Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation
用于 F508del CFTR 突变位点特异性基因组编辑的下一代三链形成肽核酸
  • DOI:
    10.1016/j.jcf.2024.07.009
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Anisha Gupta;Christina Barone;Elias Quijano;Alexandra S. Piotrowski-Daspit;J. Dinithi Perera;Adele Riccardi;Haya Jamali;Audrey Turchick;Weixi Zao;W. Mark Saltzman;Peter M. Glazer;Marie E. Egan
  • 通讯作者:
    Marie E. Egan
Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol–Coated Biodegradable Nanoparticles
通过超支化聚甘油涂层的可生物降解纳米颗粒增强免疫调节剂单磷酰脂质 A 在肿瘤内的递送
  • DOI:
    10.1016/j.jid.2024.07.019
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Jungsoo Chang;Kwangsoo Shin;Julia M. Lewis;Hee Won Suh;Joohyung Lee;William Damsky;Suzanne Xu;Marcus Bosenberg;W. Mark Saltzman;Michael Girardi
  • 通讯作者:
    Michael Girardi
436 EFFECT OF SURVIVIN SIRNA AND VEGF SIRNA COMPLEXED IN NANOPARTICLES ON BLADDER CANCER CELLS AND UROTHELIAL TISSUES
  • DOI:
    10.1016/j.juro.2010.02.507
  • 发表时间:
    2010-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Alexander Saltzman;Kim Woodrow;Marcia A. Wheeler;Avanti Verma;W. Mark Saltzman;Robert M. Weiss
  • 通讯作者:
    Robert M. Weiss
1358 NANOPARTICLE DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR PXD101 FACILITATES BLADDER CANCER CELL UPTAKE AND CYTOTOXICITY
  • DOI:
    10.1016/j.juro.2011.02.1180
  • 发表时间:
    2011-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hristos Z. Kaimakliotis;Darryl T. Martin;Christopher J. Hoimes;Christopher C. Cheng;Jingchun Liu;Wm. Kevin Kelly;Gregory N. Tew;W. Mark Saltzman;Robert M. Weiss
  • 通讯作者:
    Robert M. Weiss
Cell-binding Peptides Conjugated to Poly(ethylene glycol) Promote Neural Cell Aggregation
与聚乙二醇结合的细胞结合肽促进神经细胞聚集
  • DOI:
    10.1038/nbt0894-797
  • 发表时间:
    1994-08-01
  • 期刊:
  • 影响因子:
    41.700
  • 作者:
    Weiguo Dai;Jennifer Belt;W. Mark Saltzman
  • 通讯作者:
    W. Mark Saltzman

W. Mark Saltzman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('W. Mark Saltzman', 18)}}的其他基金

Engineering of Polymeric Particles for Fetal Therapy
用于胎儿治疗的聚合物颗粒工程
  • 批准号:
    10586282
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research
耶鲁大学糖尿病研究跨学科生物工程培训补助金
  • 批准号:
    8730154
  • 财政年份:
    2013
  • 资助金额:
    $ 26.98万
  • 项目类别:
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research
耶鲁大学糖尿病研究跨学科生物工程培训补助金
  • 批准号:
    8928174
  • 财政年份:
    2013
  • 资助金额:
    $ 26.98万
  • 项目类别:
MOLECULAR AND CELLULAR TRANSPORT IN MUCUS
粘液中的分子和细胞运输
  • 批准号:
    8357694
  • 财政年份:
    2011
  • 资助金额:
    $ 26.98万
  • 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
  • 批准号:
    8232044
  • 财政年份:
    2011
  • 资助金额:
    $ 26.98万
  • 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
  • 批准号:
    8107039
  • 财政年份:
    2011
  • 资助金额:
    $ 26.98万
  • 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
  • 批准号:
    8620614
  • 财政年份:
    2011
  • 资助金额:
    $ 26.98万
  • 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
  • 批准号:
    8444707
  • 财政年份:
    2011
  • 资助金额:
    $ 26.98万
  • 项目类别:
MOLECULAR AND CELLULAR TRANSPORT IN MUCUS
粘液中的分子和细胞运输
  • 批准号:
    8172722
  • 财政年份:
    2010
  • 资助金额:
    $ 26.98万
  • 项目类别:
Optimizing Revascularization by EC Transplantation
通过 EC 移植优化血运重建
  • 批准号:
    7633385
  • 财政年份:
    2006
  • 资助金额:
    $ 26.98万
  • 项目类别:

相似海外基金

The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
  • 批准号:
    23K06224
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
  • 批准号:
    494564
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
  • 批准号:
    495437
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
  • 批准号:
    23K08020
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
  • 批准号:
    10740433
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
  • 批准号:
    23K10101
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
  • 批准号:
    23K10809
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
  • 批准号:
    10738361
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了